Agree. Uworld QId: 3873 (Step 2) corroborates this.
The current recommendation is for those with HIV with CD4+ counts ≥ 200 to receive 2 doses of the single-antigen varicella vaccine (Varivax) which is a live-attenuated vaccine. (Varicella Vaccination for Specific Groups | Chickenpox (Varicella) | CDC)
Shingrix is also recommended for immunocompromised individuals, regardless of previous VZV vaccination status, but cannot be given sooner than 8 weeks after VZV vaccination with Varivax. (Clinical Considerations for Shingrix Use in Immunocompromised Adults Aged ≥19 Years | Shingles (Herpes Zoster) | CDC)
Recommendations on this topic will likely change in the future, so I believe it should be determined what is likely to show up on NBME exams so that the card does not become too confusing.